{"id":3989,"date":"2018-03-09T16:15:15","date_gmt":"2018-03-09T21:15:15","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3989"},"modified":"2018-03-09T16:15:15","modified_gmt":"2018-03-09T21:15:15","slug":"ipo-weekly-recap-bioxcel-therapeutics-closes-week-flat","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-bioxcel-therapeutics-closes-week-flat\/","title":{"rendered":"IPO Weekly Recap: BioXcel Therapeutics closes week flat"},"content":{"rendered":"<p><em><span style=\"font-weight: 400;\">Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the <\/span><b>TRUEST<\/b><span style=\"font-weight: 400;\"> picture of how an IPO is shaping up prior to its debut. We are on <\/span><b>your team. <\/b><span style=\"font-weight: 400;\">Additionally, we provide comprehensive research to outline short and long term risks of the new companies\u2026.. <\/span><b>A full-service firm!<\/b><\/em><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Screen-Shot-2018-03-09-at-4.13.17-PM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-3990\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Screen-Shot-2018-03-09-at-4.13.17-PM.png\" alt=\"Screen Shot 2018-03-09 at 4.13.17 PM\" width=\"1408\" height=\"82\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Screen-Shot-2018-03-09-at-4.13.17-PM.png 1408w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Screen-Shot-2018-03-09-at-4.13.17-PM-600x35.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Screen-Shot-2018-03-09-at-4.13.17-PM-300x17.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Screen-Shot-2018-03-09-at-4.13.17-PM-1024x60.png 1024w\" sizes=\"(max-width: 1408px) 100vw, 1408px\" \/><\/a><\/p>\n<p>The IPO market inched its way into March with just one IPO that came with relatively little fanfare.<\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/BioXcelTherapeutics.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-3944\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/BioXcelTherapeutics.jpg\" alt=\"BioXcelTherapeutics\" width=\"318\" height=\"72\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/BioXcelTherapeutics.jpg 318w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/BioXcelTherapeutics-300x68.jpg 300w\" sizes=\"(max-width: 318px) 100vw, 318px\" \/><\/a><\/p>\n<p><b>BioXcel Therapeutics (BTAI)<\/b><span style=\"font-weight: 400;\"> slightly upsized its offering and priced at the low-end of the $11-$13 range. BTAI opened at $11.02, broke its offering price briefly before leveling out for the week. At its top tick, BioXcel touched $11.94 or 8.5% above the offering price but the majority of the trading volume was near the offering price. BioXcel Therapeutics closed the week at the offering price, $11.00.<\/span><\/p>\n<p>Looking ahead to this week, there are three deals&#8230;which you can read a preview about by clicking on the images.<\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/bridgewater-bancshares-ipo-preview-bwb\/\" target=\"_blank\"><img decoding=\"async\" class=\"aligncenter wp-image-3981 size-full\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/BridgewaterBancshares.jpg\" alt=\"BridgewaterBancshares\" width=\"235\" height=\"129\" \/><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/zscaler-inc-ipo-preview-zs\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3977\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/Zscaler.jpg\" alt=\"Zscaler\" width=\"187\" height=\"40\" \/><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/arcus-biosciences-ipo-preview-rcus\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3973\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/03\/ArcusBiosciences.jpg\" alt=\"ArcusBiosciences\" width=\"214\" height=\"71\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3989","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3989"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3989\/revisions"}],"predecessor-version":[{"id":3991,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3989\/revisions\/3991"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}